Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Refractory (Phase 2)
Antigens, CD (Phase 1)
Bone Marrow Transplantation (Phase 3)
Glomerular Basement Membrane (Early Phase 1)
Hodgkin Disease (Phase 1)
Leukemia (Phase 2)
Leukemia, Lymphoid (Early Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Early Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Early Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Neoplasms, Germ Cell and Embryonal (Early Phase 1)
Thrombocytopenia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue